S 3510 · 119th CongressIn Committeecongress.gov ↗
Road to The Floor
How it worksIntroduced
In Committee
On The Floor
Passed a Chamber
Passed Congress
To President
Became Law
What this bill does
AI plain-language summaryThis bill appears to deal with updating or changing how inspections are carried out for biosimilar products, which are medicines that are very similar to brand-name biological drugs. No official summary is available for this bill.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.